Cargando…

Young donor white blood cell immunotherapy induces extensive tumor necrosis in advanced-stage solid tumors

BACKGROUND: In the past decade, a variety of immunotherapy approaches focused predominantly on the adaptive immune system have shown unprecedented responses in patients with advanced-stage malignancies. However, studies in spontaneous regression/complete resistance (SR/CR) mice and humans have shown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maharaj, Dipnarine, Vianna, Pedro G., Ward, Wendy, Messina, Anthony J., Rayborn, Trevor, Gouvea, Jacqueline V., Hammer, Richard D., Cui, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680985/ https://www.ncbi.nlm.nih.gov/pubmed/29159318 http://dx.doi.org/10.1016/j.heliyon.2017.e00438

Ejemplares similares

Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant
por: Maharaj, Dipnarine, et al.
Publicado: (2019)

Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV—Unmutated Chronic Lymphocytic Leukemia
por: Maharaj, Dipnarine, et al.
Publicado: (2020)

Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome
por: Maharaj, Dipnarine, et al.
Publicado: (2021)

Immunotherapy for Solid Tumors
por: de Saint Basile, Hortense, et al.
Publicado: (2023)

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014)

Extensive necrosis of visceral melanoma metastases after immunotherapy
por: Stoeter, David, et al.
Publicado: (2008)

Advances in Cancer Immunotherapy in Solid Tumors
por: Menon, Smitha, et al.
Publicado: (2016)

Assessing the Future of Solid Tumor Immunotherapy
por: Guha, Prajna, et al.
Publicado: (2022)

Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy
por: Bremer, Edwin
Publicado: (2013)

Dendritic Cell-Based Immunotherapy for Solid Tumors()()
por: Jung, Nam-Chul, et al.
Publicado: (2018)

Challenges of evaluating immunotherapy efficacy in solid tumors
por: Bai, Rilan, et al.
Publicado: (2019)

Recent updates on Sintilimab in solid tumor immunotherapy
por: Liu, Xuhong, et al.
Publicado: (2020)

TCR engineered T cells for solid tumor immunotherapy
por: Zhang, Yikai, et al.
Publicado: (2022)

Neoadjuvant immunotherapy of locoregionally advanced solid tumors
por: Tarhini, Ahmad A, et al.
Publicado: (2022)

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
por: Mercogliano, María Florencia, et al.
Publicado: (2021)

Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015)

Immunotherapy in Pediatric Solid Tumors—A Systematic Review
por: Marayati, Raoud, et al.
Publicado: (2019)

Immunotherapies for Pediatric Solid Tumors: A Targeted Update
por: Gupta, Ajay, et al.
Publicado: (2021)

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Sloas, Christopher, et al.
Publicado: (2021)

Photoimmunotherapy: A New Paradigm in Solid Tumor Immunotherapy
por: Peng, Zheng, et al.
Publicado: (2022)

Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
por: Chen, Chen, et al.
Publicado: (2022)

Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023)

Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy
por: Araujo, Daniel V, et al.
Publicado: (2021)

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
por: Sangiolo, Dario
Publicado: (2011)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
por: Kosti, Paris, et al.
Publicado: (2018)

Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects
por: Olive, D., et al.
Publicado: (2016)

Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
por: Dummer, Reinhard, et al.
Publicado: (2017)

Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST
por: Goldmacher, Gregory V., et al.
Publicado: (2020)

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
por: Vikas, Praveen, et al.
Publicado: (2020)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
por: Arora, Sanjeevani, et al.
Publicado: (2019)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors
por: Fan, Jiaqiao, et al.
Publicado: (2021)

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
por: Tan, Aaron C, et al.
Publicado: (2021)

Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021)

Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy
por: Vaflard, Pauline, et al.
Publicado: (2021)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Preclinical Study of Plasmodium Immunotherapy Combined with Radiotherapy for Solid Tumors
por: Tao, Zhu, et al.
Publicado: (2022)

Editorial: Novel immunotherapies to treat gastrointestinal solid tumor cancers
por: Sureban, Sripathi M., et al.
Publicado: (2022)

Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors
por: Kovács, Szonja Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fvffda64g5ft0bte0hhop6vmkk